Burroughs Amy L.
SEC insider (Form 3/4/5 filer). CIK 0001872564. Director at Tenaya Therapeutics, Inc. (TNYA) and 1 other issuer. 26 reported Form 4/5 transactions since Sep 2024; latest on May 28, 2026. Located in FOSTER CITY, CA.
Companies Burroughs Amy L. has filed insider reports for
- Tenaya Therapeutics, Inc. (TNYA): Director
- Terns Pharmaceuticals, Inc. (TERN): Director, Officer, Chief Executive Officer
Burroughs Amy L.
CIK: 0001872564
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- May 28, 2026TNYA
Tenaya Therapeutics, Inc.
AwardDirectStock Option (Right to buy)
120K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
Tender OfferIndirect8.3K shares at avg. $53.00$441K - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirect150K shares at avg. $53.00$8.0M - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
Tender OfferDirect146.6K shares at avg. $53.00$7.8M - Mar 16, 2026TERN
Terns Pharmaceuticals, Inc.
SaleDirect11.8K shares at avg. $46.57$550K - Mar 16, 2026TERN
Terns Pharmaceuticals, Inc.
SaleDirect2.8K shares at avg. $47.30$131K - Mar 16, 2026TERN
Terns Pharmaceuticals, Inc.
ExerciseDirect14.6K shares at avg. $4.64$68K - Feb 17, 2026TERN
Terns Pharmaceuticals, Inc.
SaleDirect2.3K shares at avg. $38.07$89K - Feb 17, 2026TERN
Terns Pharmaceuticals, Inc.
ExerciseDirect14.6K shares at avg. $4.64$68K - Feb 17, 2026TERN
Terns Pharmaceuticals, Inc.
SaleDirect8.2K shares at avg. $39.22$320K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 28, 2026 |  TNYA Tenaya Therapeutics, Inc. | Award Stock Option (Right to buy) | 120,000 | - | - | Direct |
| May 5, 2026 |  TERN Terns Pharmaceuticals, Inc. | Tender Offer | 8,319 | $53.00 | $440,907 | Indirect |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition | 150,000 | $53.00 | $7,950,000 | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Tender Offer | 146,614 | $53.00 | $7,770,542 | Direct |
| Mar 16, 2026 | TERN Terns Pharmaceuticals, Inc. | Sale | 11,813 | $46.57 | $550,081 | Direct |
| Mar 16, 2026 | TERN Terns Pharmaceuticals, Inc. | Sale | 2,770 | $47.30 | $131,028 | Direct |
| Mar 16, 2026 | TERN Terns Pharmaceuticals, Inc. | Exercise | 14,583 | $4.64 | $67,665 | Direct |
| Feb 17, 2026 | TERN Terns Pharmaceuticals, Inc. | Sale | 2,341 | $38.07 | $89,114 | Direct |
| Feb 17, 2026 | TERN Terns Pharmaceuticals, Inc. | Exercise | 14,583 | $4.64 | $67,665 | Direct |
| Feb 17, 2026 | TERN Terns Pharmaceuticals, Inc. | Sale | 8,159 | $39.22 | $319,963 | Direct |
1-10 of 26 transactions